We are proud to announce that AGILeBiotics is now a member of the BEAM Alliance, the European AMR innovation hub gathering Biopharma companies. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong Network of approx. 50 small and medium-sized European biopharmaceutical companies committed by developing innovative products to fend-off antibiotic-resistant pathogens. In 3 years of existence, the BEAM Alliance has become the major contact for policy makers when it comes to the dialogue with European biopharma SME’s developing innovative products to fight against AMR. With joined forces we fight against life-threatening multidrug-resistant infection.